Advertisement
Screener

Intuitive Surgical, Inc. (ISRG) Revenue, Net (Deprecated 2018-01-31)

2.8 / 5 stars · 68/120 Roast Me

Intuitive Surgical, Inc. Revenue, Net (Deprecated 2018-01-31)

Intuitive Surgical, Inc. (ISRG) reported Revenue, Net (Deprecated 2018-01-31) of $909.30 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-07-20.

Discontinued › Income Statement

us-gaap:SalesRevenueNet · last filed 2018-07-20

  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $909.30M, a 19.83% increase year-over-year.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $847.50M, a 24.71% increase year-over-year.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $892.40M, a 17.90% increase year-over-year.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $806.10M, a 18.04% increase year-over-year.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $3.13B, a 15.70% increase from fiscal 2016.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $2.70B, a 13.42% increase from fiscal 2015.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $2.38B, a 11.85% increase from fiscal 2014.
  • Intuitive Surgical, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $2.13B, a 5.89% decline from fiscal 2013.
Period endRevenue, Net (Deprecated 2018-01-31) 3 monthRevenue, Net (Deprecated 2018-01-31) 3 month as first filedRevenue, Net (Deprecated 2018-01-31) 6 monthRevenue, Net (Deprecated 2018-01-31) 6 month as first filedRevenue, Net (Deprecated 2018-01-31) 9 monthRevenue, Net (Deprecated 2018-01-31) 9 month as first filedRevenue, Net (Deprecated 2018-01-31) 12 monthRevenue, Net (Deprecated 2018-01-31) 12 month as first filed
2018-06-30$909.30M
10-Q · filed 2018-07-20
$1.76B
10-Q · filed 2018-07-20
$2.65B
derived: sum of 3 quarters · filed 2018-07-20
$3.46B
derived: sum of 4 quarters · filed 2018-07-20
2018-03-31$847.50M
10-Q · filed 2018-04-18
$1.74B
derived: sum of 2 quarters · filed 2018-04-18
$2.55B
derived: sum of 3 quarters · filed 2018-04-18
$3.30B
derived: sum of 4 quarters · filed 2018-07-20
2017-12-31$892.40M
10-K · filed 2018-02-02
$1.70B
derived: sum of 2 quarters · filed 2018-02-02
$2.46B
derived: sum of 3 quarters · filed 2018-07-20
$3.13B
10-K · filed 2018-02-02
2017-09-30$806.10M
10-K · filed 2018-02-02
$1.56B
derived: sum of 2 quarters · filed 2018-07-20
$2.24B
10-Q · filed 2017-10-20
$3.00B
derived: sum of 4 quarters · filed 2018-07-20
2017-06-30$758.80M
10-Q · filed 2018-07-20
$756.20M
10-Q · filed 2017-07-21
$1.44B
10-Q · filed 2018-07-20
$1.43B
10-Q · filed 2017-07-21
$2.20B
derived: sum of 3 quarters · filed 2018-07-20
$2.88B
derived: sum of 4 quarters · filed 2018-07-20
2017-03-31$679.60M
10-Q · filed 2018-04-18
$674.20M
10-Q · filed 2017-04-19
$1.44B
derived: sum of 2 quarters · filed 2018-04-18
$2.12B
derived: sum of 3 quarters · filed 2018-04-18
$2.79B
derived: sum of 4 quarters · filed 2018-04-18
2016-12-31$756.90M
10-K · filed 2018-02-02
$1.44B
derived: sum of 2 quarters · filed 2018-02-02
$2.11B
derived: sum of 3 quarters · filed 2018-02-02
$2.70B
10-K · filed 2018-02-02
2016-09-30$682.90M
10-K · filed 2018-02-02
$1.35B
derived: sum of 2 quarters · filed 2018-02-02
$1.95B
10-Q · filed 2017-10-20
$2.62B
derived: sum of 4 quarters · filed 2018-02-02
2016-06-30$670.10M
10-K · filed 2018-02-02
$1.26B
10-Q · filed 2017-07-21
$1.94B
derived: sum of 3 quarters · filed 2018-02-02
$2.53B
derived: sum of 4 quarters · filed 2018-02-02
2016-03-31$594.50M
10-K · filed 2018-02-02
$1.27B
derived: sum of 2 quarters · filed 2018-02-02
$1.86B
derived: sum of 3 quarters · filed 2018-02-02
$2.45B
derived: sum of 4 quarters · filed 2018-02-02
2015-12-31$676.50M
10-K · filed 2017-02-06
$1.27B
derived: sum of 2 quarters · filed 2017-02-06
$1.85B
derived: sum of 3 quarters · filed 2017-02-06
$2.38B
10-K · filed 2018-02-02
2015-09-30$589.70M
10-K · filed 2017-02-06
$1.18B
derived: sum of 2 quarters · filed 2017-02-06
$1.71B
10-Q · filed 2016-10-19
$2.31B
derived: sum of 4 quarters · filed 2017-02-06
2015-06-30$586.10M
10-K · filed 2017-02-06
$1.12B
10-Q · filed 2016-07-20
$1.72B
derived: sum of 3 quarters · filed 2017-02-06
$2.27B
derived: sum of 4 quarters · filed 2017-02-06
2015-03-31$532.10M
10-K · filed 2017-02-06
$1.14B
derived: sum of 2 quarters · filed 2017-02-06
$1.69B
derived: sum of 3 quarters · filed 2017-02-06
$2.20B
derived: sum of 4 quarters · filed 2017-02-06
2014-12-31$604.70M
10-K · filed 2016-02-02
$1.15B
derived: sum of 2 quarters · filed 2016-02-02
$1.67B
derived: sum of 3 quarters · filed 2016-02-02
$2.13B
10-K · filed 2017-02-06
2014-09-30$550.10M
10-K · filed 2016-02-02
$1.06B
derived: sum of 2 quarters · filed 2016-02-02
$1.53B
10-Q · filed 2015-10-21
$2.10B
derived: sum of 4 quarters · filed 2016-02-02
2014-06-30$512.20M
10-K · filed 2016-02-02
$976.90M
10-Q · filed 2015-07-22
$1.55B
derived: sum of 3 quarters · filed 2016-02-02
$2.05B
derived: sum of 4 quarters · filed 2016-02-02
2014-03-31$464.70M
10-K · filed 2016-02-02
$1.04B
derived: sum of 2 quarters · filed 2016-02-02
$1.54B
derived: sum of 3 quarters · filed 2016-02-02
$2.12B
derived: sum of 4 quarters · filed 2016-02-02
2013-12-31$576.20M
10-K · filed 2015-02-06
$1.08B
derived: sum of 2 quarters · filed 2015-02-06
$1.65B
derived: sum of 3 quarters · filed 2015-02-06
$2.27B
10-K · filed 2016-02-02
2013-09-30$499.00M
10-K · filed 2015-02-06
$1.08B
derived: sum of 2 quarters · filed 2015-02-06
$1.69B
10-Q · filed 2014-10-23
$2.30B
derived: sum of 4 quarters · filed 2015-02-06
2013-06-30$578.50M
10-K · filed 2015-02-06
$1.19B
10-Q · filed 2014-07-24
$1.80B
derived: sum of 3 quarters · filed 2015-02-06
$2.34B
derived: sum of 4 quarters · filed 2015-02-06
2013-03-31$611.40M
10-K · filed 2015-02-06
$1.22B
derived: sum of 2 quarters · filed 2015-02-06
$1.76B
derived: sum of 3 quarters · filed 2015-02-06
$2.29B
derived: sum of 4 quarters · filed 2015-02-06
2012-12-31$609.30M
10-K · filed 2014-02-03
$1.15B
derived: sum of 2 quarters · filed 2014-02-03
$1.68B
derived: sum of 3 quarters · filed 2014-02-03
$2.18B
10-K · filed 2015-02-06
2012-09-30$537.80M
10-K · filed 2014-02-03
$1.07B
derived: sum of 2 quarters · filed 2014-02-03
$1.57B
10-Q · filed 2013-10-18
$2.07B
derived: sum of 4 quarters · filed 2014-02-03
2012-06-30$536.50M
10-K · filed 2014-02-03
$1.03B
10-Q · filed 2013-07-22
$1.53B
derived: sum of 3 quarters · filed 2014-02-03
$1.98B
derived: sum of 4 quarters · filed 2014-02-03
2012-03-31$495.20M
10-K · filed 2014-02-03
$992.00M
derived: sum of 2 quarters · filed 2014-02-03
$1.44B
derived: sum of 3 quarters · filed 2014-02-03
$1.86B
derived: sum of 4 quarters · filed 2014-02-03
2011-12-31$496.80M
10-K · filed 2013-02-04
$943.50M
derived: sum of 2 quarters · filed 2013-02-04
$1.37B
derived: sum of 3 quarters · filed 2013-02-04
$1.76B
10-K · filed 2014-02-03
2011-09-30$446.70M
10-K · filed 2013-02-04
$872.40M
derived: sum of 2 quarters · filed 2013-02-04
$1.26B
10-Q · filed 2012-10-18
$1.65B
derived: sum of 4 quarters · filed 2013-02-04
2011-06-30$425.70M
10-K · filed 2013-02-04
$813.80M
10-Q · filed 2012-07-23
$1.20B
derived: sum of 3 quarters · filed 2013-02-04
$1.55B
derived: sum of 4 quarters · filed 2013-02-04
2011-03-31$388.10M
10-K · filed 2013-02-04
$777.40M
derived: sum of 2 quarters · filed 2013-02-04
$1.12B
derived: sum of 3 quarters · filed 2013-02-04
$1.47B
derived: sum of 4 quarters · filed 2013-02-04
2010-12-31$389.30M
10-K · filed 2012-02-06
$733.70M
derived: sum of 2 quarters · filed 2012-02-06
$1.08B
derived: sum of 3 quarters · filed 2012-02-06
$1.41B
10-K · filed 2013-02-04
2010-09-30$344.40M
10-K · filed 2012-02-06
$695.10M
derived: sum of 2 quarters · filed 2012-02-06
$1.02B
10-Q · filed 2011-10-19
$1.35B
derived: sum of 4 quarters · filed 2012-02-06
2010-06-30$350.70M
10-K · filed 2012-02-06
$679.30M
10-Q · filed 2011-07-20
$1.00B
derived: sum of 3 quarters · filed 2012-02-06
$1.28B
derived: sum of 4 quarters · filed 2012-02-06
2010-03-31$328.60M
10-K · filed 2012-02-06
$651.70M
derived: sum of 2 quarters · filed 2012-02-06
$931.80M
derived: sum of 3 quarters · filed 2012-02-06
$1.19B
derived: sum of 4 quarters · filed 2012-02-06
2009-12-31$323.10M
10-K · filed 2011-02-01
$603.20M
derived: sum of 2 quarters · filed 2011-02-01
$863.80M
derived: sum of 3 quarters · filed 2011-02-01
$1.05B
10-K · filed 2012-02-06
$1.05B
10-K · filed 2010-01-29
2009-09-30$280.10M
10-K · filed 2011-02-01
$280.13M
10-Q · filed 2009-10-21
$540.70M
derived: sum of 2 quarters · filed 2011-02-01
$729.10M
10-Q · filed 2010-10-20
$729.13M
10-Q · filed 2009-10-21
$960.63M
derived: sum of 4 quarters · filed 2011-02-01
2009-06-30$260.60M
10-K · filed 2011-02-01
$260.62M
10-Q · filed 2009-07-23
$449.00M
10-Q · filed 2010-07-23
$449.00M
10-Q · filed 2009-07-23
$680.53M
derived: sum of 3 quarters · filed 2011-02-01
$916.52M
derived: sum of 4 quarters · filed 2011-02-01
2009-03-31$188.40M
10-K · filed 2011-02-01
$419.93M
derived: sum of 2 quarters · filed 2011-02-01
$655.92M
derived: sum of 3 quarters · filed 2011-02-01
$875.11M
derived: sum of 4 quarters · filed 2011-02-01
2008-12-31$231.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01
$467.52M
derived: sum of 2 quarters · filed 2011-02-01
$686.71M
derived: sum of 3 quarters · filed 2011-02-01
$874.90M
10-K · filed 2011-02-01
$874.92M
10-K · filed 2010-01-29
2008-09-30$235.99M
10-Q · filed 2009-10-21
$455.18M
derived: sum of 2 quarters · filed 2009-10-21
$643.37M
10-Q · filed 2009-10-21
2008-06-30$219.19M
10-Q · filed 2009-07-23
$407.38M
10-Q · filed 2009-07-23
2007-12-31$600.83M
10-K · filed 2010-01-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edwards Lifesciences Corp (EW)United States$49.409B51.96
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81